P
Priya Gupta
Researcher at Jawaharlal Nehru University
Publications - 100
Citations - 2264
Priya Gupta is an academic researcher from Jawaharlal Nehru University. The author has contributed to research in topics: Janus kinase inhibitor & Tofacitinib. The author has an hindex of 19, co-authored 85 publications receiving 1751 citations. Previous affiliations of Priya Gupta include Pfizer & University of Delhi.
Papers
More filters
Journal ArticleDOI
Biofilm, pathogenesis and prevention—a journey to break the wall: a review
TL;DR: The aim of this review was to discuss about the basic formation of a biofilm, various signalling cascades involved in biofilm formation, possible mechanisms of drug resistance in bioFilms and recent therapeutic approaches involved in successful eradication of biofilms.
Journal ArticleDOI
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.
Kim A. Papp,Alan Menter,Bruce Strober,Richard G. Langley,Marjorie Buonanno,Robert Wolk,Priya Gupta,Sriram Krishnaswami,Huaming Tan,J. Harness +9 more
TL;DR: Tofacitinib is a novel, oral Janus kinase inhibitor under investigation as a potential treatment for plaque psoriasis.
Journal ArticleDOI
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials
Kim A. Papp,M.A. Menter,Masatoshi Abe,Boni E. Elewski,Steven R. Feldman,Alice B. Gottlieb,Richard G. Langley,T. A. Luger,Diamant Thaçi,Marjorie Buonanno,Priya Gupta,J. Proulx,Shuping Lan,Robert Wolk,Opt Pivotal investigators +14 more
TL;DR: Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis and it is unclear whether or not this drug will help treat the disease.
Journal ArticleDOI
Firm growth and its determinants
TL;DR: In this article, a framework has been designed to study the path followed by small and medium enterprises (SMEs) by considering the influence of internal and external environmental factors on the growth patterns of SMEs.
Journal ArticleDOI
Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin
Manash C. Das,Padmani Sandhu,Priya Gupta,Prasenjit Rudrapaul,Utpal Chandra De,Prosun Tribedi,Yusuf Akhter,Surajit Bhattacharjee +7 more
TL;DR: Results showed marked attenuation in biofilm formation and QS mediated phenotype of Pseudomonas aeruginosa in presence of 110 μg/ml vitexin in combination with azithromycin and gentamicin separately.